|
AVTE Aerovate Therapeutics Inc 1798749 |
| Balance Sheet |
|
Current Assets
|
90,605,000 |
|
Assets
|
90,959,000 |
|
Current Liabilities
|
10,315,000 |
|
Liabilities
|
10,466,000 |
|
Equity
|
80,493,000 |
|
Shares Out
|
28,868,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-60,149,000 |
|
Investing Cash Flow
|
42,900,000 |
| Market Analysis |
Market Cap
|
54,271,294 |
|
Price
|
2.50 |
|
BVPS
|
2.79 |
|
PB
|
0.90 |
|
EPS
|
-3.14 |
|
PS
|
0.27 |
|
FCF
|
-17,249,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVTE documents filed with the SEC.
AVTE Filings
Clear
